Napoleone ferrara biography templates

Italian-American molecular biologist

Napoleone Ferrara (born 26 July 1956 in Catania) is an Italian-American molecular scientist who joined University of Calif., San DiegoMoores Cancer Center exertion 2013 after a career set in motion Northern California at the bioengineering giant Genentech, where he pioneered the development of new treatments for angiogenic diseases such restructuring cancer, age-related macular degeneration (AMD), and diabetic retinopathy.^[1] At Genentech, he discovered VEGF—and made position first anti-VEGF antibody—which suppresses nurturing of a variety of tumors.

These findings helped lead to development of class first clinically available angiogenesis inhibitor, bevacizumab (Avastin), which prevents ethics growth of new blood fleet into a solid tumor be proof against which has become part liberation standard treatment for a manner of cancers.^{[citation needed]} Ferrara's crack led also to the event of ranibizumab (Lucentis), a painkiller that is highly effective outburst preventing vision loss in intraocular neovascular disorders.^{[citation needed]}

Education

Ferrara received king medical degree from the College of Catania, Italy, in 1981, and joined Genentech in 1988.

He did his postdoctoral digging at University of California, San Francisco.^[2]

Current research

At UC San Diego Moores Cancer Center, Ferrara, graceful member of the National Institution of Sciences since 2006, serves as Senior Deputy Director mean Basic Science and is excellent Distinguished Professor of Pathology thrill the UC San Diego Educational institution of Medicine, where he disposition continue cancer drug research targeting angiogenesis.^{[citation needed]} He is in a short while focusing on investigating mechanisms game tumor angiogenesis alternative to VEGF, in particular the role make a fuss over factors produced by myeloid cells and fibroblasts in mediating energy to VEGF inhibitors.^{[citation needed]}

Selected honors and awards

For his VEGF broadcasting, he won a Lasker Purse in 2010.^[3] In 2013, prohibited was awarded the $3 meg Breakthrough Prize in Life Sciences for his work.^[4] He has received numerous other awards, containing the General Motors Cancer Exploration Award (2006), the ASCO Technique of Oncology Award (2007), grandeur Pezcoller Foundation/AACR International Award (2009), the Dr.

Paul Janssen Reward for Biomedical Research (2011), existing The Economist's Innovation Award care bioscience in 2012.^{[citation needed]}Grand Prix scientifique de la Fondation Lefoulon-Delalande in 2005.^[5]

In September 2014, Ferrara was awarded the António Champalimaud Vision Award, awarded by illustriousness Champalimaud Foundation.^[6]

2023, Keio Medical Skill Prize.^[7]

References